Peter S. Sever

Imperial College, London, UK

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers246 papers

Sort

By YearBy Citation

Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials

Baris Gencer, Nicholas A Marston,KyungAh Im,Christopher P Cannon,Peter Sever,Anthony Keech,Eugene Braunwald,Robert P Giugliano,Marc S Sabatine

Lancet (London, England), no. 10263 (2020): 1637-1643

WOSBibtex

LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial

Peter Sever,Ioanna Gouni-Berthold,Anthony Keech,Robert Giugliano,Terje R Pedersen,KyungAh Im, Huei Wang, Beat Knusel,Marc S Sabatine,Michelle L O'Donoghue

European journal of preventive cardiology, pp.2047487320902750, (2020)

WOSBibtex

Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score

Nicholas A. Marston, Frederick K. Kamanu,Francesco Nordio, Yared Gurmu, Carolina Roselli,Peter S. Sever,Terje R. Pedersen,Anthony C. Keech, Huei Wang, Armando Lira Pineda,Robert P. Giugliano,Steven A. Lubitz

Circulation, (2020)

Bibtex

Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis

Robert P Giugliano,Terje R Pedersen,Jeffrey L Saver,Peter S Sever,Anthony C Keech,Erin A Bohula,Sabina A Murphy,Scott M Wasserman,Narimon Honarpour, Huei Wang, Armando Lira Pineda,Marc S Sabatine

Stroke, no. 5 (2020): 1546-1554

WOSBibtex

Effect of Evolocumab on Type and Size of Subsequent Myocardial Infarction: A Prespecified Analysis of the FOURIER Randomized Clinical Trial

Stephen D Wiviott,Robert P Giugliano,David A Morrow,Gaetano M De Ferrari,Basil S Lewis,Kurt Huber,Julia F Kuder,Sabina A Murphy, Danielle M Forni, Christopher E Kurtz,Narimon Honarpour,Anthony C Keech

JAMA cardiology, (2020)

WOSBibtex

Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: A Prespecified Secondary Analysis From the FOURIER Trial

Baris Gencer, François Mach,Sabina A Murphy,Gaetano M De Ferrari,Kurt Huber,Basil S Lewis, Jorge Ferreira, Christopher E Kurtz, Huei Wang,Narimon Honarpour,Anthony C Keech,Peter S Sever

JAMA cardiology, (2020)

WOSBibtex

The Effect of PCSK9 Inhibition on the Risk of Venous Thromboembolism

Nicholas A Marston, Yared Gurmu, Giorgio E M Melloni,Marc Bonaca,Baris Gencer,Peter S Sever,Terje R Pedersen,Anthony C Keech, Carolina Roselli,Steven A Lubitz, Patrick T Ellinor,Michelle L O'Donoghue

Circulation, (2020)

WOSBibtex

Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial

Nicholas A Marston, Frederick K Kamanu,Francesco Nordio,Yared Gurmu, Carolina Roselli,Peter S Sever,Terje R Pedersen,Anthony C Keech, Huei Wang, Armando Lira Pineda,Robert P Giugliano,Steven A Lubitz

Circulation, (2019)

WOSBibtex

EFFICACY AND SAFETY OF LONG-TERM EVOLOCUMAB USE IN ASIAN VERSUS OTHER SUBJECTS: THE FOURIER TRIAL

Anthony C. Keech,Peter Sever, Lixin Jiang,Atsushi Hirayama, Chen Lu, Leslie Tay,Prakash Deedwania, Chung-Wah Siu, Armando Lira Pineda,Donghoon Choi,Min-Ji Charng,John Amerena

Journal of the American College of Cardiology, no. 9 (2019): 189

Bibtex

Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial

David M Charytan,Marc S Sabatine,Terje R Pedersen,KyungAh Im, Jeong-Gun Park, Armando Lira Pineda,Scott M Wasserman,Prakash Deedwania,Anders G Olsson,Peter S Sever,Anthony C Keech,Robert P Giugliano

Journal of the American College of Cardiology, no. 23 (2019): 2961-2970

WOSBibtex

Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular Disease: A Prespecified Analysis From the FOURIER Trial

Sabina A Murphy,Terje R Pedersen,Zbigniew A Gaciong,Richard Ceska,Marat V Ezhov,Derek L Connolly,J Wouter Jukema,Kalman Toth,Matti J Tikkanen,Kyungah Im,Stephen D Wiviott, Christopher E Kurtz

JAMA cardiology, (2019)

WOSBibtex

Association of Nonfasting vs Fasting Lipid Levels With Risk of Major Coronary Events in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm

Samia Mora, C Lan Chang, M Vinayaga Moorthy,Peter S Sever

JAMA internal medicine, (2019)

WOSBibtex

The importance of a valid assessment of salt intake in individuals and populations. A scientific statement of the British and Irish Hypertension Society

Francesco P Cappuccio,Peter S Sever

Journal of human hypertension, pp.1, (2019)

WOSBibtex

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk

Michelle L. O’Donoghue,Sergio Fazio,Robert P. Giugliano,Erik S.G. Stroes, Estella Kanevsky,Ioanna Gouni-Berthold,KyungAh Im, Armando Lira Pineda,Scott M. Wasserman,Richard Češka,Marat V. Ezhov,J. Wouter Jukema

Circulation, (2019)

Bibtex

RS13. Risk of Major Adverse Limb Events and Benefits of Evolocumab in Patients With Peripheral Artery Disease by History of Prior Peripheral Revascularization

Patrice Nault,Marc Bonaca,Robert P. Giugliano,Narimon Honarpour,Anthony C. Keech,Peter S. Sever,Terje R. Pedersen,Marc Sabatine

Journal of Vascular Surgery, no. 6 (2019)

Bibtex

Efficacy and Safety of Incremental Dosing of a New Single-Pill Formulation of Perindopril and Amlodipine in the Management of Hypertension

Neil R Poulter,Eamon Dolan,Ajay K Gupta,Eoin O'Brien,Andrew Whitehouse,Peter S Sever

American Journal of Cardiovascular Drugs, no. 3 (2019): 313-323

WOSBibtex

Reply to Chiolero: Salt intake monitoring at a population level

Francesco P. Cappuccio,Peter S. Sever

Journal of Human Hypertension, pp.1-2, (2019)

Bibtex

Correction: Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial (vol 73, pg 2961, 2019)

DM Charytan,Sabatine, TR Pedersen,J-G Park, AL Pineda, SM Wasserman,P Deedwania, AG Olsson,PS Sever, AC Keech, RP Giugliano

Journal of the American College of Cardiology, (2019)

Bibtex

Inflammatory and Cholesterol Risk in the FOURIER Trial

Erin A. Bohula,Robert P. Giugliano,Lawrence A. Leiter,Subodh Verma, Jeong-Gun Park,Peter Sever, Armando Lira Pineda,Narimon Honarpour,Huei Wang,Sabina A. Murphy,Anthony Keech,Terje R. Pedersen

Circulation, no. 2 (2018): 131-140

Cited by21Bibtex

5002Benefit of LDL-C lowering with evolocumab on cardiovascular outcomes by age & sex: an analysis of the FOURIER trial

Peter Sever,Ioanna Gouni-Berthold,Anthony Keech,Robert P. Giugliano,T Pedersen,Scott M. Wasserman,KyungAh Im,Marc S. Sabatine,Michelle L. O'Donoghue, Fourier Trial

European Heart Journal, (2018)

Bibtex

View All

Base Info Papers Patents Projects